Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
GlobeNewswire, Inc.
PARMA, Italy, June 05, 2026 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced that the European...
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
GlobeNewswire, Inc.
CHICAGO, June 04, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its proprietary brand, Sky Premium Life, is now...
Sweden Calls On Parents to Cut Phone Use Around Kids
MENAFN
(MENAFN) Sweden's Public Health Agency issued a stark warning to parents Monday, calling on them to significantly reduce personal mobile phone use in the presence of children — pointing to a mounting body of evidence that adults' own screen habits...
Sweden Advises Parents to Cut Back Phone Use in Presence of Children
MENAFN
(MENAFN) Sweden’s Public Health Agency has issued a new recommendation urging parents to limit their mobile phone use in the presence of children, pointing to growing evidence that adult screen habits can have a negative impact on child...
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
GlobeNewswire, Inc.
BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver...
Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders
GlobeNewswire, Inc.
-- At ERA 2026, Chiesi will contribute to advancing the scientific understanding of Fabry disease and nephropathic cystinosis through real-world experience and clinical outcomes, supporting the needs of the community of today -- -- Chiesi will...
FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate
GlobeNewswire, Inc.
Exceptional track record across multiple clinical development programs for depression, three of which have resulted in regulatory approvals Appointment strengthens confidence in clinical readiness and execution as the Company progresses toward...
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
GlobeNewswire, Inc.
SEATTLE, May 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...
Imviva Biotech to Present Data from Clinical Studies of CTA313 and CTD402 Validating its ANSWER™ Allogeneic CAR-T Platform in Pediatric and Adult Patient Populations at EULAR and EHA 2026 Congresses
GlobeNewswire, Inc.
BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational dual-targeted...
5,000 Swedes sign on to protect the Swedish success story
GlobeNewswire, Inc.
STOCKHOLM, May 21, 2026 (GLOBE NEWSWIRE) -- The campaign Den Svenska Succén has today passed 5,000 signatures from Swedes calling for snus and white snus to be protected as a cornerstone of Sweden's public health policy.
CryoTEM breaks ground as new method added to U.S. Pharmacopeia's updated AAV reference standard certificates
EIN Presswire
USP recognizes CryoTEM for characterizing empty/full/intermediate capsids on AAV8 reference standards STOCKHOLM, STOCKHOLM, SWEDEN, May 20, 2026 /EINPresswire.com/ -- QuTEM announces that cryo-transmission electron microscopy (CryoTEM) has been...
Sweden Reassures Public Over Hantavirus Outbreak Linked to Cruise Ship
MENAFN
(MENAFN) Swedish health officials have moved to calm public concern over a hantavirus outbreak connected to the cruise ship MV Hondius, saying there is no indication of a wider public health threat or emerging pandemic, according to reports from...
Fascia Clinics Calls for Broader Approach to Pelvic Floor Dysfunction Following New Swedish National Guidelines
EIN Presswire
Woman with severe pelvic floor dysfunction was told a stoma was her only option.
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
GlobeNewswire, Inc.
BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...
![[Latest] Global Cholera Vaccine Market Size/Share Worth USD 649 Million by 2035 at a 7.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/f83c044b-a0c2-40b3-9736-3f7637645436/north-america-cholera-vaccine-market-size-2025-to-2035-usd-million-.png)
[Latest] Global Cholera Vaccine Market Size/Share Worth USD 649 Million by 2035 at a 7.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, May 19, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Cholera Vaccine Market Size, Trends and Insights By Type (Whole Cell v. Cholerae O1 with Recombinant B- subunit, Killed Oral O1 and...
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire, Inc.
BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient...
Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm
GlobeNewswire, Inc.
May 18, 2026 Philips-led consortium selected through Karolinska University Hospital-led Region Stockholm tender to deliver advanced remote monitoring for complex patients Stockholm, Sweden - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in...
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
GlobeNewswire, Inc.
WELLESLEY HILLS, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced an upcoming presentation on its...
Stephen Shaya, M.D. Honored in Historic Exchange Between the Imperial House of Brazil and Swedish Orders
EIN Presswire
STOCKHOLM, SWEDEN, May 13, 2026 /EINPresswire.com/ -- Stephen Shaya, M.D., Executive Servant Leader of J&B Medical and Managing Director of Akkad Holdings, was honored during a historic exchange of honors between the Imperial House of Brazil,...
Berry Street Partners with Factor, Bringing Personalized Nutrition Therapy to Leading Meal Delivery Service
GlobeNewswire, Inc.
NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Berry Street, the leading metabolic health company transforming nutrition therapy, and Factor, America’s leading ready-to-heat meal delivery service, today announced a new partnership to provide...
Sign up for:
Swedish Health Press
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.